Sort
40,608 grants matching “prostate cancer”
Prostate Cancer Immunotherapy
$310,970Lawrence Fong · University Of California, San Francisco · R01 · FY2012 · CA
Androgen Receptor Function in Prostate Cancer
$310,970Richard G Pestell · Thomas Jefferson University · R01 · FY2012 · CA
High Density Lipoprotein Nanoparticles for siRNA Delivery
$310,970Colby Shad Thaxton · Northwestern University At Chicago · R01 · FY2014 · CA
External validation of GEMCaP, a prognostic DNA biomarker set for CaP recurrence
$310,970Pamela L Paris · University Of California, San Francisco · R01 · FY2014 · CA
Regulation and function of the YAP transcription co-activator oncoprotein
$310,970Kun-Liang Guan · University Of California, San Diego · R01 · FY2011 · CA
Small molecule inhibitors of Wnt-2 transcription in NSCLC
$310,970Biao He · University Of California, San Francisco · R01 · FY2011 · CA
Androgen Receptor Function in Prostate Cancer
$310,970Richard G Pestell · Thomas Jefferson University · R01 · FY2011 · CA
Stromal AR Roles in Prostate Hyperplasia and Cancer
$310,970Chawnshang Chang · University Of Rochester · R01 · FY2014 · CA
Prostate Cancer Immunotherapy
$310,970Lawrence Fong · University Of California, San Francisco · R01 · FY2011 · CA
Nucleoside ribohydrolases as targets for Trichomonas vaginalis therapeutic agents. This project will evaluate two essential nucleoside ribohydrolase enzymes as targets for novel antitrichomonal drugs.
$310,934Brian J Stockman · Adelphi University · R15 · FY2017 · AI
Progenitor cells of the mouse prostate epithelium
$310,928Michael M. Shen · Columbia University Health Sciences · R01 · FY2010 · DK
Modulation of host intrinsic immunity to reduce prostate cancer disparity
$310,904Dev Karan · Medical College Of Wisconsin · R01 · FY2018 · CA
Novel roles of microRNA in androgen receptor signaling
$310,892Allen C Gao · University Of California At Davis · R01 · FY2014 · CA
Mechanisms of Murine Tumor Eradication by Immunotherapy
$310,881Philip D Greenberg · University Of Washington · R01 · FY2009 · CA
BIOLOGICALLY ACTIVE STEROID ANALOGS
$310,854Yale University · R01 · FY2005 · CA
BIOLOGICALLY ACTIVE STEROID ANALOGS
$310,854Yale University · R01 · FY2003 · CA
BIOLOGICALLY ACTIVE STEROID ANALOGS
$310,854Yale University · R01 · FY2004 · CA
BIOLOGICALLY ACTIVE STEROID ANALOGS
$310,854Yale University · R01 · FY2002 · CA
Administrative Core
$310,853Christopher J. Logothetis · University Of Tx Md Anderson Can Ctr · P50 · FY2016 · CA
Prostatic Differentiation and Sex Hormone Metabolism
$310,838University Of Cincinnati · R01 · FY2005 · CA
Functional Imaging of the Metastatic Phenotype
$310,791Zaver M Bhujwalla · Johns Hopkins University · R01 · FY2014 · CA
Detection of microsatellite instability biomarkers for therapeutic clinical trial eligibility
$310,771Sameek Roychowdhury · Ohio State University · UH3 · FY2019 · CA
Targeting Nanoparticle DNA Delivery to Prostate Tumors
$310,762Janet A. Sawicki · Lankenau Institute For Medical Research · R01 · FY2008 · CA
University of Michigan Comprehensive Cancer Center Support Grant
$310,728Theodore S Lawrence · University Of Michigan At Ann Arbor · P30 · FY2014 · CA
The Risk of Developing Alzheimer's Disease and Related Dementias Associated with Hypertension, Diabetes, and Drug Therapies for Cancer: Up to 30-year Follow-up for Older Medicare Beneficiaries
$310,666Xianglin Du · University Of Texas Hlth Sci Ctr Houston · R01 · FY2020 · AG